Improved second phase insulin secretion and preserved insulin sensitivity after islet transplantation

Transplantation

Volumn 89, Issue 10, 2010, Pages 1291-1293

  Vethakkan, Shireene R ^a,b,d   Jenkins, Alicia J ^b   Kay, Thomas W H ^b,c   Goodman, David J ^a   Walters, Jacqueline M ^b   Gooley, Judith L ^b   Boston, Raymond C ^e   Holmes Walker, D Jane ^f   Ward, Glenn M ^a  

^a St Vincent's Health Melbourne ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

BODY MASS; GRAFT REJECTION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LETTER; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR;

AWARENESS; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77952818032     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d45ab3     Document Type: Letter

References (11)

1. Rickels MR, Schutta MH, Mueller R, et al. Islet cell hormonal responses to hypoglyce-mia after human islet transplantation for Type 1 Diabetes. Diabetes 2005; 54: 3205.
2. Rickels MR, Naji A, Teff KL. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 2006; 91: 2138.
3. Ryan EA, Paty BW, Senior PA,etal. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
4. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
5. Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710.
6. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
7. Luzi L, Hering BJ, Socci C, et al. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 2611.
8. Rickels MR, Mueller R, Naji A./3-cell secretory capacity and insulin sensitivity in recipients of islet, pancreas and kidney transplants. Diabetes 2009; 58(suppl 1): A103.
9. Luzi L, Secchi A, Facchini F, et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in Type 1 (insulin-dependent) diabetic patients. Diabetologia 1990; 33: 549.
10. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002; 18: 192.
11. Leslie RD, Taylor R, Pozzilli P. The role of insulin resistance in the natural history of type 1 diabetes. Diabet Med 1997; 14: 327.